27. Al-Naml/The Ant
I/We begin by the Blessed Name of Allah
The Immensely Merciful to all, The Infinitely Compassionate to everyone.
27:01
a. Ta. Sin.
b. These are the Messages of The Divine Qur’an, and, a Clear Book.
27:02
a. It is a Guidance, and,
b. a source of good news for the believers.
27:03
a. The believers are those who:
- establish the Salat/Prayers, and
- pay out the Zakat/annual charity, and
- it is they who believe with certainty in the realm of the Hereafter.
27:04
a. Surely, as for those who do not believe in the realm of the Hereafter,
b. WE have made their evil deeds appear enticing to them,
c. so that they wander confused in their worldly lives.
27:05
a. It is they for whom is going to be an awful punishment,
b. and it is they who are going to be the worst losers in the realm of the Hereafter.
27:06
a. And, for sure, you - O The Prophet – are receiving the Qur’an from the One WHO is
All-Wise, All-Knowing.
27:07
a. And visualize the time when Moses said to his family:
b. ‘I believe - I perceive a fire on the mountain.
c. You wait here I will go and bring you some information from there, or at least a firebrand
- so you may warm up yourselves.’
27:08
a. So when he came close to it, a Voice called out:
b. ‘Blessed be WHOEVER is within the Fire, and whoever is around it!
c. And Exalted be Allah - Rabb - The Lord...
Background: Chronic myelogenous Leukemia is a form of cancer that was firstly recognizes to associate strongly with the chromosomal abnormality [t (9; 22) translocation] called Philadelphia chromosome. Objective: Philadelphia chromosome is a characteristic chromosomal marker that is associated with chronic myelogenous leukemia. Methods: More than one hundred patients of either sex were selected for the experiment. RNA was isolated from whole blood of patients so can use exclusively in RT-PCR. Results: Philadelphia chromosome in blood samples of patients with suspected diagnosis of CML was detected in 63% of patients. During our experimental studies on CML patients we do not encounter any complex translocation involving chromosome 8, 9 and 22. Conclusions: Philadelphia chromosome is a precise cytogenetic marker the detection of which is significant for differential diagnosis and clinical organization of patients with clinical diagnosis of CML. It is of significant that Ph chromosome occurs in pre-leukemic stage and has great diagnostic significance.
Introduction: At population level, a caesarean section (CS) rate between 10 and 15 percent is considered optimal for maternal and infant health outcomes and a useful process indicator of quality of care. However, that there has been a worldwide increase of CS rates in the past three decades. Compared to vaginal birth, questions abide of appropriateness, balance of risk versus benefit and cost implications to the health care system. Introduction of free maternity services (FMS) in June 2013has been known to increase health facility deliveries. However it may affect the quality of care offered in these facilities due to a strain in human and financial resources. Caesarean section rates and more importantly the potentially preventable CS can be used as a measure of quality of care as suggested by the World Health Organization (WHO). Objectives: The primary objectives included a comparison of CS rates three years before and three years after FMS and to study the effect of FMS on indications particularly the rate of potentially preventable CS (Robson group 1-4) before and after introduction of FMS. The secondary objective was the effect of FMS on short term adverse maternal and neonatal outcomes of the CSs. Methods: The study was conducted in Maragua Level IV Hospital in Muranga County, using a cross-sectional retrospective before and after study. The implementation of FMS services in June 2013 were used as the midpoint. The source was the obstetric database with the pre-implementation period being (June 2010 to May 2013) and post-implementation period (June 2013 to May 2016). A sample size of 1182 was calculated, distributed proportionally between the two arms; 264 in the pre-FMS and 918 post-FMS period. Proportionate sampling to ensure equal distribution of the sample proportional to the percentage of all CS in each year was used. A data collection tool based on the Robson Classification was employed to collect relevant data from the CS files. Maternal and neonatal outcomes were analysed. Comparisons of the change in variables were done by use of two sample test of independent proportion and Chi-square test as appropriate. Results: The hospital deliveries increased from (n=4518) in the pre-FMS period to (n=8612) after introduction of FMS; 557 women (12.3%) had a Caesarean Section in the pre FMS period as compared to 1998 (23.2%) in the post FMS years, an increase of 10.9% (p<0.001) in CS rate. There were no significant changes in outcomes of maternal and